precisionmedicineonline2h
FDA Clears Lion TCR to Begin Phase II Trial of TCR T-Cell Therapy in HBV-Related Liver Cancer
The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.
Zacks.com on MSN7h
GILD Stock Up on Q4 Earnings and Sales Beat & Upbeat '25 Guidance
Gilead Sciences, Inc. GILD reported better-than-expected fourth-quarter results and provided an upbeat guidance for 2025.
Is Arbutus Biopharma Corp. (ABUS) the Best Nasdaq Stock Under $5 to Buy?
We recently published a list of 10 Best Nasdaq Stocks Under $5 to Buy. In this article, we are going to take a look at where Arbutus Biopharma Corp.
manilatimes8h
Aligos Therapeutics Announces $105 Million Private Placement Financing
Aligos currently expects to use the net proceeds from the private placement, together with its existing cash, cash ...
Taiwan News14h
Taiwan study reveals link between hepatitis B, fatty liver disease, and mortality rate
TAIPEI (Taiwan News) — A study conducted by National Taiwan University Hospital has uncovered a link between hepatitis B, ...
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma
Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from ...
10 Best Nasdaq Stocks Under $5 to Buy
The Nasdaq is one of the top three most-followed stock market indices in the United States, comprising over 2,500 stocks.
NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape
SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the 'Company') declared today that it is ready to fight the bird f ...